GENE ONLINE|News &
Gastric Cancer
Innovent Announces Gastric Cancer Trial Win for Tyvyt, Reveals Plans for Another China Approval
2021-08-16
Day 2 ASCO 2021 Roundup: Focus on Equity in Cancer Care, Highlights from Breast Cancer and Gastrointestinal Cancer Studies
2021-06-06
BMS’s Drug Bags First FDA-Approved Immunotherapy Tag for Initial Treatment of Gastric Cancer
2021-04-19
Amgen Signs $1.9 Billion Worth Cancer Deal, Nurtures Growth Aspirations in Asia with New Oncology Assets
2021-03-07
AstraZeneca, Daiichi Sankyo’s Potential Blockbuster Bags Second US Approval, This Time for Gastric Cancer
2021-01-22
China-Based Immunotherapy Company Receives FDA’s Orphan Drug Designation for Advanced Gastric Cancer Treatment
2020-10-07
ASCO 2020: AstraZeneca and Daiichi Sankyo’s Enhertu Impresses with Benefits in Lung, Stomach and Colorectal Cancer Trials
2020-06-05
